Katarzyna Osetek-Müller, PhD, is a scientist specializing
in immunoassays, molecular biology, and genetics.
At Bavarian Nordic in Martinsried near Munich, she
leads the development of an ELISA assay to replace
animal testing in quality control of the Tick-Borne
Encephalitis (TBE) vaccine and evaluates
immunoreactivity of the Chikungunya Virus-like Particle
(CHIKV VLP) vaccine.
Previously, Katarzyna was Team Lead and Deputy
Head of Reproductive Genetics at MVZ Martinsried
GmbH (Medicover Genetics), where she managed an
international team and advanced molecular diagnostics
for reproductive health. Her expertise includes assay
development and validation, whole genome
amplification, next-generation sequencing, and
diagnostics for monogenic disorders and infertility.
She earned her PhD in Regenerative Sciences from
Hannover Medical School, studying pluripotent stem cell
induction and genetic stability, and a Master
’
s in
Biology from Jagiellonian University, focusing on gene
mapping in mouse gametes.
Outside the lab, Katarzyna enjoys skiing, dancing, and
traveling.